Market Overview:
The global rapid testing devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of infectious diseases, growing demand for point-of-care testing, and technological advancements in rapid testing devices. Based on type, the global rapid testing devices market is segmented into urine testing devices and oral fluid testing devices.
Product Definition:
A rapid testing device is a small, hand-held device that tests for the presence of a specific substance in a sample. These devices are often used to test for the presence of drugs or alcohol in urine or saliva. They are also used to test for certain infections, such as HIV and hepatitis C. Rapid testing devices are important because they allow healthcare workers and others to quickly and easily screen for certain illnesses or substances.
Urine Testing Devices:
Urine testing devices are used for the detection of various substances such as drugs, metabolites, and toxins in human urine. The increasing prevalence of diseases such as diabetes and kidney disease is expected to drive the global market. For instance, according to a study conducted by the International Diabetes Federation (IDF), around 463 million people were suffering from diabetes globally in 2014 which is anticipated to reach 700 million by 2045.
Oral Fluid Testing Devices:
Oral fluid testing devices are used for the collection of oral fluids such as saliva, blood, and mucous from the patient. These oral fluids are then sent to a laboratory for analysis. The results of these tests can be used by healthcare professionals to diagnose various medical conditions including diabetes, cancer, cardiovascular diseases and others.
Application Insights:
The other application segment includes use in food & beverage, textile, pharmaceuticals and cosmetics industries. The market is expected to witness growth owing to the increasing number of accredited third-party laboratories across the world that are involved in quality control of these products. For instance, FDA has issued a directive for all manufacturers and private lab owners regarding implementation of polices related to rapid testing devices for drugs & biologics quality.
Rapid testing devices help detect various substances such as amphetamine, barbiturates, benzene compounds (volatile organic compounds), cannabis (marijuana), cocaine base (crack cocaine), methamphetamines/amphetamine sulfate/speed®, opiates including heroin and morphine®, phencyclidine hydrochloride or PCP® among others. These substances are either illegal or have been legalised under different names such as marijuana legalization in various states within U.S.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of R&D facilities and biotechnology & pharmaceutical companies is one of the major factors contributing to regional growth. In addition, increasing government initiatives for drug testing programs are also expected to drive the market over the forecast period. For instance, as per an article published by Clinical Chemistry and Laboratory Medicine in 2016, around 50 million Americans have taken prescription drugs at some point in their lives but not necessarily every day or always taken them as prescribed (i.e., pharmacy-based medication management).
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments across emerging economies such as China & India coupled with growing healthcare expenditure levels within these countries.
Growth Factors:
- Increasing demand for rapid testing devices in the life sciences sector to support drug discovery and development processes.
- Growing demand for point-of-care (POC) testing due to the increasing incidence of infectious diseases and rising healthcare costs.
- Proliferation of home health care services, which is driving the need for rapid diagnostic tests that can be used in a home setting.
- The increasing use of rapid diagnostic tests by hospitals and other healthcare facilities as a means of reducing patient wait times and improving overall efficiency.
Scope Of The Report
Report Attributes
Report Details
Report Title
Rapid Testing Devices Market Research Report
By Type
Urine Testing Devices, Oral Fluid Testing Devices
By Application
Hospital, Biotechnology & Pharmaceutical Companies, Private Labs, Research Institute, Other
By Companies
Quest Diagnostics, Abbott, Roche, Thermo Fisher, Dragerwerk, Siemens, Express, Shimadzu, MPD, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
169
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Rapid Testing Devices Market Report Segments:
The global Rapid Testing Devices market is segmented on the basis of:
Types
Urine Testing Devices, Oral Fluid Testing Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Biotechnology & Pharmaceutical Companies, Private Labs, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quest Diagnostics
- Abbott
- Roche
- Thermo Fisher
- Dragerwerk
- Siemens
- Express
- Shimadzu
- MPD
- Quest Diagnostics
Highlights of The Rapid Testing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Urine Testing Devices
- Oral Fluid Testing Devices
- By Application:
- Hospital
- Biotechnology & Pharmaceutical Companies
- Private Labs
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rapid Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rapid testing devices are a type of testing equipment that can help speed up the process of performing quality assurance (QA) or quality control (QC) tests. They typically consist of a number of different tools and sensors that allow testers to quickly and easily perform various types of tests on a variety of products.
Some of the major companies in the rapid testing devices market are Quest Diagnostics, Abbott, Roche, Thermo Fisher, Dragerwerk, Siemens, Express, Shimadzu, MPD, Quest Diagnostics.
The rapid testing devices market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rapid Testing Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rapid Testing Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rapid Testing Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rapid Testing Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rapid Testing Devices Market Size & Forecast, 2018-2028
4.5.1 Rapid Testing Devices Market Size and Y-o-Y Growth
4.5.2 Rapid Testing Devices Market Absolute $ Opportunity
Chapter 5 Global Rapid Testing Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Rapid Testing Devices Market Size Forecast by Type
5.2.1 Urine Testing Devices
5.2.2 Oral Fluid Testing Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Rapid Testing Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Rapid Testing Devices Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Biotechnology & Pharmaceutical Companies
6.2.3 Private Labs
6.2.4 Research Institute
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rapid Testing Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rapid Testing Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Rapid Testing Devices Analysis and Forecast
9.1 Introduction
9.2 North America Rapid Testing Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Rapid Testing Devices Market Size Forecast by Type
9.6.1 Urine Testing Devices
9.6.2 Oral Fluid Testing Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Rapid Testing Devices Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Biotechnology & Pharmaceutical Companies
9.10.3 Private Labs
9.10.4 Research Institute
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Rapid Testing Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Rapid Testing Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Rapid Testing Devices Market Size Forecast by Type
10.6.1 Urine Testing Devices
10.6.2 Oral Fluid Testing Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Rapid Testing Devices Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Biotechnology & Pharmaceutical Companies
10.10.3 Private Labs
10.10.4 Research Institute
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Rapid Testing Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Rapid Testing Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Rapid Testing Devices Market Size Forecast by Type
11.6.1 Urine Testing Devices
11.6.2 Oral Fluid Testing Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Rapid Testing Devices Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Biotechnology & Pharmaceutical Companies
11.10.3 Private Labs
11.10.4 Research Institute
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Rapid Testing Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Rapid Testing Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Rapid Testing Devices Market Size Forecast by Type
12.6.1 Urine Testing Devices
12.6.2 Oral Fluid Testing Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Rapid Testing Devices Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Biotechnology & Pharmaceutical Companies
12.10.3 Private Labs
12.10.4 Research Institute
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Rapid Testing Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Rapid Testing Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Rapid Testing Devices Market Size Forecast by Type
13.6.1 Urine Testing Devices
13.6.2 Oral Fluid Testing Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Rapid Testing Devices Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Biotechnology & Pharmaceutical Companies
13.10.3 Private Labs
13.10.4 Research Institute
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rapid Testing Devices Market: Competitive Dashboard
14.2 Global Rapid Testing Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Quest Diagnostics
14.3.2 Abbott
14.3.3 Roche
14.3.4 Thermo Fisher
14.3.5 Dragerwerk
14.3.6 Siemens
14.3.7 Express
14.3.8 Shimadzu
14.3.9 MPD
14.3.10 Quest Diagnostics
